Phase II Trial of Reduced Intensity Busulfan / Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with AML, MDS, and ALL
2014 ◽
Vol 20
(2)
◽
pp. S217-S218
2020 ◽
Vol 26
(2)
◽
pp. 316-322
2013 ◽
Vol 19
(10)
◽
pp. 1453-1458
◽
2018 ◽
Vol 24
(11)
◽
pp. 2310-2315
◽
2007 ◽
Vol 82
(10)
◽
pp. 873-880
◽
2011 ◽
Vol 17
(2)
◽
pp. S291
2020 ◽
2003 ◽
Vol 9
(3)
◽
pp. 162-169
◽
2003 ◽
Vol 9
(2)
◽
pp. 99-100